Amylin gains on sale rumors

Amylin Pharmaceuticals Inc. (NASDAQ:AMLN) jumped $3.14 (14%) to $26.06 on Monday on reports that the company hired Credit Suisse and Goldman Sachs to explore a sale of the company. Amylin, Credit Suisse and Goldman Sachs all declined to comment. ...